| 摘要 |
A method of inhibiting one or more symptom of premenstrual syndrome/late luteal phase dysphoric disorder comprising administering to a female human in need of treatment an effective amount of a compound having the formula <IMAGE> (I) wherein R1 and R3 are independently hydrogen, -CH3, -CO-(C1-C6 alkyl), or -CO-Ar, in which Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidino, hexamethyleneimino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
|
